Pinealon dosing schedule
Human schedule
Controlled data on this compound are limited. The regimens below were gathered from public sources online (studies and protocols) and are given as a reference, not a usage plan.
Pinealon (Glu-Asp-Arg, EDR) is administered mainly subcutaneously, once daily, in research protocols. The schedule below is a reference generalized from described regimens and the reconstituted product, not a clinically validated protocol.
This is a concise reference to regimens described for adults; it is not an individual prescription.
| Period / condition | Dose | Escalation |
|---|---|---|
| Days 1–5 | 1.0 mg (1000 mcg) once daily, subcutaneous | Starting dose |
| Days 6–14 | 1.5 mg (1500 mcg) once daily, subcutaneous | Increase if needed |
| Days 15–20 | 2.0 mg (2000 mcg) once daily, subcutaneous | Maximum in this schedule |